Stockhead TV
Check out the latest Medtech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Stockhead TV
Long Shortz with Lumos Diagnostics: Attention from the globe as antimicrobial resistance takes flight
Stockhead TV
Long Shortz with Orthocell: Gateway to Asia open with Singapore market entry
Health & Biotech
Health Check: Fresh from its FDA win, Echo IQ aims for even bigger heart failure approval
Health & Biotech
Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market
Health & Biotech
User base expands for HeraMED’s remote pregnancy monitoring platform
Health & Biotech
Orthocell secures regulatory approval to launch Remplir sales in Singapore
Health & Biotech
Lodge Partners sees 430% upside for Blinklab, developer of smartphone autism test
Health & Biotech
‘Closer to US commercialisation’ – EBR achieves major FDA milestone
Health & Biotech
Health Check: Probiotics supplier has gut feeling about surging growth
Stockhead TV
Long Shortz with PharmAust: Sweet incentives for sad disease’s drug development
Health & Biotech
EBR begins $50m capital raise to commercialise WiSE leadless pacemaker
Health & Biotech
Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval
Stockhead TV
Long Shortz with EBR Systems: regulatory submission a major milestone
Health & Biotech
‘Significant milestone’ – EBR submits final PMA module to FDA
Health & Biotech
Lumos Diagnostics seals deal to advance point-of-care test to monitor liver health
Health & Biotech
CBL lifts on NeuroNode’s approval as reimbursable medical device in US
Health & Biotech
Optiscan joins with US uni to improve cancer detection in animals
Health & Biotech
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Health & Biotech
First US patient treated in Imricor cardiac ablation trial
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Health & Biotech
NorthStar sees good impact in Control Bionics, invests $525k
Health & Biotech
BlinkLab partners with Mental Care Group to advance ADHD diagnostics in Europe
Stockhead TV
Break it Down: Optiscan Imaging to transform digital pathology
Health & Biotech
Imricor Medical Systems raising $35m to fund growth strategy
Health & Biotech
Vital Signs Podcast: Optiscan
Health & Biotech
Orthocell to sell Striate+ in Canada after regulatory approval
Health & Biotech
Investors are all ears as Orthocell’s nerve and tissue solutions deliver record revenue
Health & Biotech
Imricor starts global trial for US FDA approval
Health & Biotech
‘Significant milestone’: Optiscan soars on new InVue imaging device for precision surgery
Stockhead TV
Long Shortz with Optiscan Imaging: Life-saving deal with Mayo Clinic years in the making
Health & Biotech
With FDA approval close, Echo IQ’s AI platform is set to disrupt US heart disease market
Health & Biotech
Medtech Imricor ‘laying the foundations’ for growth after momentum builds in Q1 CY24
Stockhead TV
Long Shortz with Optiscan Imaging: To the US – and the moon!
Aftermarket
What is amycretin? The new weight-loss pill that’s ‘twice as effective’ as Ozempic
News
ASX Rebalance: Tech in, lithium out of S&P/ASX 200 as uranium stocks enter S&P/ASX 300
Experts
Dr Boreham’s Crucible: Don’t have a heart attack, CSL’s profit-making ability is in the blood
Health & Biotech
Dr Boreham’s Crucible: ResMed holders breathe easy – those fat-busting needles have only hurt a little bit
Stockhead TV
What’s in store for 2024: Optiscan
Tech
Stock Insiders: Optiscan is expanding and the potential is enormous
Health & Biotech
Huge IPO interest and not lithium? LTR Pharma could be the next big thing on the ASX
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Tech
Optiscan’s platform could address global pathologist shortage
News
Closing Bell: Friday takes a bite out of ASX, even as biotech and lithium small caps run amok
Tech
‘Take advantage of market consolidation’: EYE ready for proposed US Medicare changes
Health & Biotech
‘Diagnose on the spot’: Optiscan’s platform brings together surgeons and pathologists for better cancer outcomes
Health & Biotech
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging
Health & Biotech
MDMA and magic mushrooms have arrived: Australia lets psychs find a new way for happy to fight sad
Load More